相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transport of Fibroblast Growth Factor 2 in the Pericellular Matrix Is Controlled by the Spatial Distribution of Its Binding Sites in Heparan Sulfate
Laurence Duchesne et al.
PLOS BIOLOGY (2012)
Highly Sulfated Nonreducing End-derived Heparan Sulfate Domains Bind Fibroblast Growth Factor-2 with High Affinity and Are Enriched in Biologically Active Fractions
Hicham Naimy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome
Alessandro Ori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Extended N-Sulfated Domains Reside at the Nonreducing End of Heparan Sulfate Chains
Gregory O. Staples et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Computational Approach for Deciphering the Organization of Glycosaminoglycans
Jean L. Spencer et al.
PLOS ONE (2010)
Basement membrane proteoglycans: Modulators Par Excellence of cancer growth and angiogenesis
Renato V. Iozzo et al.
MOLECULES AND CELLS (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Control of Growth Factor Networks by Heparan Sulfate Proteoglycans
Kimberly Forsten-Williams et al.
ANNALS OF BIOMEDICAL ENGINEERING (2008)
Inhibition of histone acetyltransferase by glycosaminoglycans
Jo Ann Buczek-Thomas et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
The Fgf families in humans, mice, and zebrafish: Their evolutional processes and roles in development, metabolism, and disease
Nobuyuki Itoh
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung
S. M. Thompson et al.
PEDIATRIC SURGERY INTERNATIONAL (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Syndecans in wound healing, inflammation and vascular biology
Annika N. Alexopoulou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Heparin oligosaccha rides as potential therapeutic agents in senile dementia
Qing Ma et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites
Maria Mitsi et al.
BIOCHEMISTRY (2006)
New insights into the inhibition of human neutrophil elastase by heparin
Jean L. Spencer et al.
BIOCHEMISTRY (2006)
Interactions between heparan sulfate and proteins: the concept of specificity
Johan Kreuger et al.
JOURNAL OF CELL BIOLOGY (2006)
Receptor specificity of the fibroblast growth factor family - The complete mammalian FGF family
Xiuqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis
Lars Jakobsson et al.
DEVELOPMENTAL CELL (2006)
Low-molecular-weight heparins and angiogenesis - Review article
K Norrby
APMIS (2006)
Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin
NJ Harmer et al.
BIOCHEMICAL JOURNAL (2006)
Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1•FGFR2c•heparin ternary complexes
CJ Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effects of receptor clustering on ligand dissociation kinetics:: Theory and simulations
M Gopalakrishnan et al.
BIOPHYSICAL JOURNAL (2005)
Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans
CL Chu et al.
BIOCHEMISTRY (2005)
Fibrillin-1 interactions with heparin - Implications for microfibril and elastic fiber assembly
SA Cain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Syndecans - New kids on the signaling block
E Tkachenko et al.
CIRCULATION RESEARCH (2005)
Mechanical interactions between collagen and proteoglycans: implications for the stability of lung tissue
FSA Cavalcante et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Heparan sulfate-protein interactions: therapeutic potential through structure-function insights
DR Coombe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's disease
L Bergamaschini et al.
JOURNAL OF NEUROSCIENCE (2004)
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism
CL Chu et al.
BIOCHEMICAL JOURNAL (2004)
Elastase mediates the release of growth factors from lung in vivo
JA Buczek-Thomas et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGIF receptor - Heparin complex
NJ Harmer et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
The heparins and cancer: review of clinical trials and biological properties
R Castelli et al.
VASCULAR MEDICINE (2004)
Pathogenic factors in vascular dementia and Alzheimer's disease - Multiple actions of heparin that probably are beneficial
H Engelberg
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Chronic obstructive pulmonary disease: molecular and cellular mechanisms
PJ Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Heparan sulfate-FGF10 interactions during lung morphogenesis
KI Izvolsky et al.
DEVELOPMENTAL BIOLOGY (2003)
Regulation of vascular endothelial growth factor binding and activity by extracellular pH
AL Goerges et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice
SD Shapiro et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Heparin derivatives as angiogenesis inhibitors
M Presta et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Heparan sulfate depletion within pulmonary fibroblasts: Implications for elastogenesis and repair
JA Buczek-Thomas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Roles of heparan-sulphate glycosaminoglycans in cancer
R Sasisekharan et al.
NATURE REVIEWS CANCER (2002)
Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions
Z Shriver et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Improved cancer mortality with low-molecular-weight heparin treatment: A review of the evidence
RH Cosgrove et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Role of heparan sulfate in fibroblast growth factor signalling: a structural view
L Pellegrini
CURRENT OPINION IN STRUCTURAL BIOLOGY (2001)
Order out of complexity - protein structures that interact with heparin
B Mulloy et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2001)
Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly
K Tiedemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase
GK Dhoot et al.
SCIENCE (2001)
Heparin and heparan sulfate: biosynthesis, structure and function
R Sasisekharan et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2000)
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
L Pellegrini et al.
NATURE (2000)
Potential mechanisms for the regulation of growth factor binding by heparin
KE Forsten et al.
JOURNAL OF THEORETICAL BIOLOGY (2000)
Specificities of heparan sulphate proteoglycans in developmental processes
N Perrimon et al.
NATURE (2000)
The molecular basis of lung morphogenesis
D Warburton et al.
MECHANISMS OF DEVELOPMENT (2000)
Fibroblast growth factor-2
MA Nugent et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
Low-molecular-weight heparin and cancer
LR Zacharski et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2000)
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
J Schlessinger et al.
MOLECULAR CELL (2000)
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions
S Tumova et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
分享论文
